![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:734138 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SYTL4 mRNA | CTD | PMID:22079256 | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:734139 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of SYTL4 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | increases expression | ISO | RGD:734139 | 6480464 | Ethinyl Estradiol results in increased expression of SYTL4 mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:734139 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SYTL4 mRNA | CTD | PMID:17942748 | 17beta-estradiol | multiple interactions | ISO | RGD:734138 | 6480464 | EGF protein inhibits the reaction [Estradiol results in increased expression of SYTL4 mRNA] | CTD | PMID:24758408 | 17beta-estradiol | increases expression | ISO | RGD:734138 | 6480464 | Estradiol results in increased expression of SYTL4 mRNA | CTD | PMID:24758408 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:734139 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SYTL4 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SYTL4 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:734138 | 6480464 | Tetrachlorodibenzodioxin affects the expression of SYTL4 mRNA | CTD | PMID:22298810 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SYTL4 mRNA | CTD | PMID:22298810 | 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:734139 | 6480464 | Fenretinide results in increased expression of SYTL4 mRNA | CTD | PMID:28973697 | 4-hydroxyphenyl retinamide | decreases expression | ISO | RGD:734139 | 6480464 | Fenretinide results in decreased expression of SYTL4 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of SYTL4 mRNA | CTD | PMID:24780913 | acrolein | multiple interactions | ISO | RGD:734138 | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SYTL4 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SYTL4 mRNA | CTD | PMID:32699268 | aflatoxin B1 | decreases methylation | ISO | RGD:734138 | 6480464 | Aflatoxin B1 results in decreased methylation of SYTL4 gene | CTD | PMID:27153756 | alpha-pinene | multiple interactions | ISO | RGD:734138 | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SYTL4 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SYTL4 mRNA | CTD | PMID:32699268 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of SYTL4 mRNA | CTD | PMID:16483693 | aristolochic acid A | decreases expression | ISO | RGD:734138 | 6480464 | aristolochic acid I results in decreased expression of SYTL4 mRNA | CTD | PMID:33212167 | Aroclor 1254 | decreases expression | ISO | RGD:734139 | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of SYTL4 mRNA | CTD | PMID:23650126 | arsane | multiple interactions | ISO | RGD:734138 | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SYTL4 mRNA | CTD | PMID:32525701 | arsenic atom | multiple interactions | ISO | RGD:734138 | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SYTL4 mRNA | CTD | PMID:32525701 | arsenite(3-) | multiple interactions | ISO | RGD:734138 | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to SYTL4 mRNA] | CTD | PMID:32406909 | benzo[a]pyrene | affects methylation | ISO | RGD:734138 | 6480464 | Benzo(a)pyrene affects the methylation of SYTL4 5' UTR more ... | CTD | PMID:27901495 | bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:734138 | 6480464 | Diethylhexyl Phthalate results in increased expression of SYTL4 mRNA | CTD | PMID:31163220 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SYTL4 mRNA | CTD | PMID:25181051, PMID:31129395 | bisphenol A | decreases expression | ISO | RGD:734139 | 6480464 | bisphenol A results in decreased expression of SYTL4 mRNA | CTD | PMID:32156529 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with tributyltin] results in decreased expression of SYTL4 mRNA | CTD | PMID:31129395 | carbon nanotube | decreases expression | ISO | RGD:734139 | 6480464 | Nanotubes more ... | CTD | PMID:25620056 | CGP 52608 | multiple interactions | ISO | RGD:734138 | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to SYTL4 gene] | CTD | PMID:28238834 | chromium(6+) | decreases expression | ISO | RGD:734138 | 6480464 | chromium hexavalent ion results in decreased expression of SYTL4 mRNA | CTD | PMID:30690063 | copper(II) sulfate | increases expression | ISO | RGD:734138 | 6480464 | Copper Sulfate results in increased expression of SYTL4 mRNA | CTD | PMID:19549813 | coumestrol | multiple interactions | ISO | RGD:734138 | 6480464 | [Coumestrol co-treated with 2 more ... | CTD | PMID:19167446 | cyclosporin A | decreases expression | ISO | RGD:734138 | 6480464 | Cyclosporine results in decreased expression of SYTL4 mRNA | CTD | PMID:20106945 | dorsomorphin | multiple interactions | ISO | RGD:734138 | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of SYTL4 mRNA | CTD | PMID:29391264 | Enterolactone | multiple interactions | ISO | RGD:734138 | 6480464 | [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SYTL4 mRNA | CTD | PMID:19167446 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of SYTL4 mRNA | CTD | PMID:33387578 | linsidomine | increases oxidation | EXP | | 6480464 | linsidomine results in increased oxidation of SYTL4 protein | CTD | PMID:28086193 | manganese(II) chloride | increases expression | EXP | | 6480464 | manganese chloride results in increased expression of SYTL4 mRNA | CTD | PMID:28801915 | methylmercury chloride | decreases expression | ISO | RGD:734138 | 6480464 | methylmercuric chloride results in decreased expression of SYTL4 mRNA | CTD | PMID:28001369 | N-nitrosodiethylamine | increases expression | ISO | RGD:734138 | 6480464 | Diethylnitrosamine results in increased expression of SYTL4 mRNA | CTD | PMID:21527772 | ozone | multiple interactions | ISO | RGD:734138 | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SYTL4 mRNA more ... | CTD | PMID:32699268 | panobinostat | multiple interactions | ISO | RGD:734138 | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYTL4 mRNA | CTD | PMID:27188386 | paracetamol | affects expression | ISO | RGD:734139 | 6480464 | Acetaminophen affects the expression of SYTL4 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of SYTL4 mRNA | CTD | PMID:33387578 | paracetamol | decreases expression | ISO | RGD:734138 | 6480464 | Acetaminophen results in decreased expression of SYTL4 mRNA | CTD | PMID:26690555 | pirinixic acid | multiple interactions | ISO | RGD:734138 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SYTL4 mRNA | CTD | PMID:19710929 | pirinixic acid | increases expression | ISO | RGD:734139 | 6480464 | pirinixic acid results in increased expression of SYTL4 mRNA | CTD | PMID:20813756, PMID:23811191 | pirinixic acid | multiple interactions | ISO | RGD:734139 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SYTL4 mRNA | CTD | PMID:19710929 | potassium chromate | multiple interactions | ISO | RGD:734138 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SYTL4 mRNA | CTD | PMID:22079256 | potassium chromate | decreases expression | ISO | RGD:734138 | 6480464 | potassium chromate(VI) results in decreased expression of SYTL4 mRNA | CTD | PMID:22079256, PMID:22714537 | progesterone | increases expression | ISO | RGD:734138 | 6480464 | Progesterone results in increased expression of SYTL4 mRNA | CTD | PMID:20864642 | quercetin | increases expression | ISO | RGD:734138 | 6480464 | Quercetin results in increased expression of SYTL4 mRNA | CTD | PMID:21632981 | resveratrol | multiple interactions | ISO | RGD:734138 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of SYTL4 mRNA | CTD | PMID:19167446 | resveratrol | increases expression | ISO | RGD:734138 | 6480464 | resveratrol results in increased expression of SYTL4 mRNA | CTD | PMID:19167446 | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of SYTL4 protein | CTD | PMID:35544339 | SB 431542 | multiple interactions | ISO | RGD:734138 | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | decreases expression | ISO | RGD:734138 | 6480464 | Silicon Dioxide analog results in decreased expression of SYTL4 mRNA | CTD | PMID:25895662 | sodium arsenate | multiple interactions | ISO | RGD:734138 | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SYTL4 mRNA | CTD | PMID:32525701 | succimer | multiple interactions | ISO | RGD:734138 | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SYTL4 mRNA | CTD | PMID:26378955 | sunitinib | decreases expression | ISO | RGD:734138 | 6480464 | Sunitinib results in decreased expression of SYTL4 mRNA | CTD | PMID:31533062 | thimerosal | decreases expression | ISO | RGD:734138 | 6480464 | Thimerosal results in decreased expression of SYTL4 mRNA | CTD | PMID:27188386 | tributylstannane | decreases expression | EXP | | 6480464 | tributyltin results in decreased expression of SYTL4 mRNA | CTD | PMID:31129395 | tributylstannane | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with tributyltin] results in decreased expression of SYTL4 mRNA | CTD | PMID:31129395 | trichloroethene | decreases methylation | EXP | | 6480464 | Trichloroethylene results in decreased methylation of SYTL4 gene | CTD | PMID:27618143 | trichostatin A | increases expression | ISO | RGD:734138 | 6480464 | trichostatin A results in increased expression of SYTL4 mRNA | CTD | PMID:24935251, PMID:26272509 | trichostatin A | multiple interactions | ISO | RGD:734138 | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYTL4 mRNA | CTD | PMID:27188386 | triptonide | increases expression | ISO | RGD:734139 | 6480464 | triptonide results in increased expression of SYTL4 mRNA | CTD | PMID:33045310 | tris(2-butoxyethyl) phosphate | affects expression | ISO | RGD:734138 | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of SYTL4 mRNA | CTD | PMID:29024780 | valproic acid | affects expression | ISO | RGD:734139 | 6480464 | Valproic Acid affects the expression of SYTL4 mRNA | CTD | PMID:17963808 | valproic acid | increases expression | ISO | RGD:734138 | 6480464 | Valproic Acid results in increased expression of SYTL4 mRNA | CTD | PMID:19101580 more ... | valproic acid | multiple interactions | ISO | RGD:734138 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYTL4 mRNA | CTD | PMID:27188386 | vorinostat | multiple interactions | ISO | RGD:734138 | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYTL4 mRNA | CTD | PMID:27188386 | vorinostat | increases expression | ISO | RGD:734138 | 6480464 | vorinostat results in increased expression of SYTL4 mRNA | CTD | PMID:26272509, PMID:27188386 | |